Navigation Links
Monmouth Medical Center Performs New Incisionless Procedure to Treat Weight Regain After Gastric Bypass
Date:4/8/2008

LONG BRANCH, N.J., April 8, 2008 /PRNewswire/ -- Monmouth Medical Center has become one of the first hospitals in the United States and the only hospital in New Jersey to offer a new incisionless procedure to reverse weight gain after gastric bypass surgery.

Steven Gorcey, MD, division chief of Gastroenterology at Monmouth Medical Center and Frank Borao, MD, chief of Minimally Invasive Surgery and medical director of Monmouth's Bariatric Surgery Program, performed the first two procedures on February 29. The incision-free procedure, which physicians have coined "ROSE" (Restorative Obesity Surgery, Endolumenal), reduces the size of a patient's stomach pouch and stoma to the original post-gastric bypass proportions to help them back onto the path of weight loss.

"Gastric bypass patients work very hard to manage their weight and adjust their lifestyle after surgery," Dr. Gorcey said. "Sometimes, through no fault of their own or their surgeon, the benefits of the bypass procedure are not permanent." He added, "To date, revision options have been expensive, difficult to perform and risky for the patient, effectively leaving them without any treatment options. Now, with this new incisionless procedure being offered at Monmouth Medical Center, we have a new and dramatically less invasive way to correct a key cause of weight regain."

Gastric bypass surgery offers the most effective means possible to lose weight. It is not, however, always a permanent fix. Up to 44 percent of patients who undergo gastric bypass begin to regain weight - and the dangerous co-morbidities associated with it - a few years after their initial operation.

Studies show that post-gastric bypass weight regain sometimes occurs because the stomach pouch and the opening to the small intestine (the stoma) slowly stretch out, allowing the patient to eat more without feeling full. Invasive procedures to restore the anatomy to the original post-surgery proportions have been
'/>"/>

SOURCE Monmouth Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Medical Errors Costing U.S. Billions
2. William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education
3. Johns Hopkins Medical School Sets Research and Teaching Collaboration with University of Patras in Greece
4. Medical errors cost US $8.8B, result in 238,337 potentially preventable deaths: HealthGrades study
5. VNUS Medical Technologies to Report First-Quarter 2008 Results and Webcast Teleconference on April 21
6. Medical Device Manufacturers Association Joins the National Healthcare Career Network
7. ReBuilder Medical Technologies, Inc. Seeks a Bigger and More Credible Equity Market - NASDAQ, here we come!
8. Edmond Medical Center to Provide Free Cataract Surgeries
9. Medical Futures signs North American licensing rights to New Biologic agent for Ulcerative Colitis
10. Pioneering Heart Surgeon, Robert E. Michler, M.D., Appointed Chair of Surgery and Surgeon-in-Chief at Einstein and at Montefiore Medical Center
11. Parker Extends Precise Medical Seal Capability; Acquires Hi-Tech Group Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... has selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation Improvement (CDI) ... ezNLP, and a patent pending ICD-10 solution - ezCAC is an enterprise-level coding ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Castle Dermatology Institute ... practice. Dr. Pedram Ghasri is a graduate of the University of California, Los Angeles. ... his studies at the University of California, Irvine Medical School. As a nationally recognized ...
(Date:8/31/2015)... ... August 31, 2015 , ... “My mother and husband ... inventor, from Hagerhill, Ky. “I thought there could be a comfortable way to prevent ... The Nasal Cannula Ear Protector offers a more secure way to anchor the cannula ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... A year ... the team is preparing to release a new issue commemorating the successful first year. ... information they need for a potentially difficult time in their lives,” says Melissa Wolfert, ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s big news for ... the digital healthcare industry. , Consumer driven health plans (CDHPs) are a growing ... advisory and strategic role to the company, and another to answer customers’ questions directly. ...
Breaking Medicine News(10 mins):Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3
... Mountain View, CA December 5, 2008 ... on developing technologies and products for immune disorders, ... therapeutic treatment for Graft versus Host Disease (GvHD) ... being held December 6 through 9 in San ...
... pseudoephedrine for kids under 2 poses toxicity issues because ... -- Exposure to the decongestant pseudoephedrine, found in many ... among children in the United States. , This is ... the highest risk for toxicity and for whom safe ...
... a USGS study released today,showing that man-made chemicals remained ... the Water Quality Association is encouraging consumers,to educate themselves ... According to a report by the U.S. Geological ... removed by public treatment processes. The,USGS examined water ...
... Launched by Product Stewardship Institute and King Pharmaceuticals ... 5 /PRNewswire-USNewswire/ - - The Product Stewardship ... Dialogue Meeting earlier this week in Washington, DC ... medications to combat increasing rates of prescription drug abuse, ...
... AIDS-causing virus don,t get sick , , FRIDAY, Dec. 5 (HealthDay ... of how a small number of HIV-infected people manage to ... medicine. , The key seems to be an unusual feature ... hope it might lead to better drug therapies or even ...
... another reason to quit smoking, consider that it may diminish ... the University of Rochester Medical Center have found that women ... were significantly more likely to face fertility problems and suffer ... non-smoking women showed those who were exposed to second hand ...
Cached Medicine News:Health News:Decongestant Exposure Needs Closer Look 2Health News:Chemicals Remain in Most Treated Water, Says Report 2Health News:Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications 2Health News:Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications 3Health News:Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications 4Health News:Special Immune Cells May Be Key to HIV Resistance 2Health News:Secondhand smoke raises odds of fertility problems in women 2
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, 2015 /PRNewswire/ ... and the life sciences team at Google announced today ... for people with type 1 and type 2 diabetes. ... with Google,s expertise in analytics, miniaturized electronics and low ... improve diabetes care by developing new tools that bring ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
(Date:8/31/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... biopharmaceutical company focused on developing and commercializing novel ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
... 15 Omega 3 fatty acids bound to,phospholipids ... natural,alternative and may have beneficial effect on impulsivity ... While several studies have reported,beneficial effects of omega-3 ... have specific positive effects on,impulse control., These ...
... May 14 Biopure Corporation,(Nasdaq: BPUR ... its Phase II coronary,revascularization trial have been ... is entitled "Proof-of-concept trial to,evaluate haemoglobin based ... protocol design, and haemodynamic,results." The manuscript was ...
Cached Medicine Technology:Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 2Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 3
... a two chain (alpha- and beta-subunits) glycoprotein ... the placenta and is normally found in ... the trophoblastic epithelium of the placenta, hCG ... the early stages of pregnancy. The primary ...
... for movement is critical ... wheelchairs. Thats why this ... technology to do just ... state-of-the-art technology, these wheelchair ...
When patients are less mobile our ProPlus™ Stand-On Scale with built-in wheels moves easily to them. Extremely durable and safe, the easy grip handrail and non-skid platform provide added suppo...
... 100 provides a new screening, diagnostic, treatment ... medical management of sleep-related breathing disorders. The ... unmet need for an ambulatory, reliable, patient ... to the great number of OSA sufferers, ...
Medicine Products: